Blog & Actualités

Insights & Actualités Tech

Découvrez nos derniers articles sur le développement web, le design et les technologies digitales qui façonnent l'avenir

Recherche pour : "biotech"
Effacer les filtres
The Download: supercharged scams and studying AI healthcare

The Download: supercharged scams and studying AI healthcare

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. We’re in a new era of AI-driven scams When ChatGPT was released in late 2022, it showed how easily generative AI could create human-like text. This...

Health-care AI is here. We don’t know if it actually helps patients.

Health-care AI is here. We don’t know if it actually helps patients.

I don’t need to tell you that AI is everywhere. Or that it is being used, increasingly, in hospitals. Doctors are using AI to help them with notetaking. AI-based tools are trawling through patient records, flagging people who may require certain support or treatments. They are also used to...

AI at MIT

AI at MIT

At MIT, AI has become so pervasive that you can almost find your way into it without meaning to. Take Sili Deng, an associate professor of mechanical engineering. Deng says she still doesn’t know whether she’d have gone all in on artificial intelligence had it not been for the covid pandemic....

Colossal Biosciences said it cloned red wolves. Is it for real?

Colossal Biosciences said it cloned red wolves. Is it for real?

If you want to capture something wolflike, it’s best to embark before dawn. So on a morning this January, with the eastern horizon still pink-hued, I drove with two young scientists into a blanket of fog. Forty miles to the west, the industrial sprawl of Houston spawned a golden glow. Tanner...

No one’s sure if synthetic mirror life will kill us all

No one’s sure if synthetic mirror life will kill us all

For four days in February 2019, some 30 synthetic biologists and ethicists hunkered down at a conference center in Northern Virginia to brainstorm high-risk, cutting-­edge, irresistibly exciting ideas that the National Science Foundation should fund. By the end of the meeting, they’d landed on a...

Coming soon: 10 Things That Matter in AI Right Now

Coming soon: 10 Things That Matter in AI Right Now

Each year we compile our 10 Breakthrough Technologies list, featuring our educated predictions for which technologies will have the biggest impact on how we live and work. This year, however, we had a dilemma. While our final picks encompass all our core coverage areas (energy, AI, and biotech,...

The Download: how humans make decisions, and Moderna’s “vaccine” word games

The Download: how humans make decisions, and Moderna’s “vaccine” word games

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. You have no choice in reading this article—maybe How do humans make decisions? The question has been on Uri Maoz’s mind since he read an article in...

What’s in a name? Moderna’s “vaccine” vs. “therapy” dilemma

What’s in a name? Moderna’s “vaccine” vs. “therapy” dilemma

Is it the Department of Defense or the Department of War? The Gulf of Mexico or the Gulf of America? A vaccine—or an “individualized neoantigen treatment”? That’s the Trump-era vocabulary paradox facing Moderna, the covid-19 shot maker whose plans for next-generation mRNA vaccines against flus and...

The Download: plastic’s problem with fuel prices, and SpaceX’s blockbuster IPO

The Download: plastic’s problem with fuel prices, and SpaceX’s blockbuster IPO

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Fuel prices are soaring. Plastic could be next.  As the war in Iran continues, one of the most visible global economic ripple effects has been...

Inside the stealthy startup that pitched brainless human clones

Inside the stealthy startup that pitched brainless human clones

After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing. In an interview with Wired, R3 listed three...